Grifols GRFS
NASDAQ GRFS
$8.00 +0.01 (+0.13%)
At close: Aug 21, 2026 · 4:00 PM EDT

Grifols (GRFS) Change in Intangibles (2010 - 2020)

Grifols' (GRFS) quarterly Change in Intangibles came in at -$28.9 million in Q1 2020, down 54.18% YoY from -$63.1 million in Q2 2019, and up 60.41% on a QoQ basis from -$73.0 million in Q4 2019.

Grifols (GRFS) Change in Intangibles (2010 - 2020) Analysis & Trends

Grifols (GRFS) has 11 years of Change in Intangibles data on file, last reported at -$28.9 million in Q1 2020.

  • Quarterly Change in Intangibles fell 54.18% year-over-year to -$28.9 million in Q1 2020, while the trailing twelve-month figure through Mar 2020 was -$73.9 million (down 373.3% YoY) and the FY2021 annual result came in at -$77.5 million, up 17.67% from the prior year.
  • Change in Intangibles improved to -$28.9 million in Q1 2020, from -$73.0 million in the prior quarter.
  • In the past five years, Change in Intangibles ranged from a high of $46.8 million in Q4 2018 to a low of -$73.0 million in Q4 2019.
  • A 5-year average of -$8.1 million and a median of $4.1 million in 2017 frame the typical range for Change in Intangibles.
  • Annual changes were most pronounced in 2016 — Change in Intangibles slumped 854.1% — and 2018, when it surged 364.21%.
  • Tracing GRFS's Change in Intangibles over 5 years: stood at $35.5 million in 2016, then fell by 15.11% to $30.1 million in 2017, then soared by 55.34% to $46.8 million in 2018, then tumbled by 256.18% to -$73.0 million in 2019, then jumped by 60.41% to -$28.9 million in 2020.
  • The last three Change in Intangibles figures came in at -$28.9 million (Q1 2020), -$73.0 million (Q4 2019), and -$18.8 million (Q1 2019), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Intangibles (Qtr)
1 Johnson & Johnson 652.20 Bn 631.44 Bn 17.26 Bn -
2 AbbVie 469.51 Bn 462.94 Bn 12.70 Bn -
3 Merck 376.81 Bn 369.67 Bn 12.21 Bn -
4 Novartis Ag 303.04 Bn 295.35 Bn 11.24 Bn -
5 Astrazeneca 257.61 Bn 252.71 Bn 12.86 Bn -
6 Amgen 237.37 Bn 223.38 Bn 7.24 Bn -
7 Gilead Sciences 181.73 Bn 178.55 Bn 6.22 Bn -
8 Pfizer 159.66 Bn 147.96 Bn 10.94 Bn -
9 Gsk 106.24 Bn 102.07 Bn 8.24 Bn 393.11 Mn
10 Grifols 5.45 Bn 4.45 Bn - -

Historic Data

Download Data
DateValue
Mar 31, 2020 -28.91 Mn
Mar 31, 2020 -28.91 Mn
Dec 31, 2019 -73.03 Mn
Dec 31, 2019 -73.03 Mn
Mar 31, 2019 -18.75 Mn
Mar 31, 2019 -18.75 Mn
Dec 31, 2018 46.76 Mn
Dec 31, 2018 46.76 Mn
Jun 30, 2018 -62.47 Mn
Jun 30, 2018 -62.47 Mn
Mar 31, 2018 18.84 Mn
Mar 31, 2018 18.84 Mn
Dec 31, 2017 30.10 Mn
Dec 31, 2017 30.10 Mn
Jun 30, 2017 18.45 Mn
Jun 30, 2017 18.45 Mn
Mar 31, 2017 4.06 Mn
Mar 31, 2017 4.06 Mn
Dec 31, 2016 35.46 Mn
Dec 31, 2016 35.46 Mn